Lv1
74 积分 2024-09-24 加入
Supplementary Figure 1 from Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
19天前
已关闭
Engineering innate immune cells for cancer immunotherapy
3个月前
已完结
tRNA m1A modification orchestrates STING translation in macrophages to enhance antitumor immunity and CAR-macrophage immunotherapy
3个月前
已完结
An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
4个月前
已完结
Human chimeric antigen receptor macrophages for cancer immunotherapy
4个月前
已完结
Induction Condition Optimization of the M-CSF-Induced Mouse Bone Marrow-Derived Macrophage and the Mechanism Exploration Based on RNA-Seq Analysis
6个月前
已完结
Therapeutic Targeting of the Tumor Microenvironment
8个月前
已完结
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1
8个月前
已完结
A second-generation M1-polarized CAR macrophage with antitumor efficacy
9个月前
已完结
A second-generation M1-polarized CAR macrophage with antitumor efficacy
11个月前
已完结
皖公网安备34019202002308
